Insurers Face Scrutiny Over ACA Policy Terminations Amid Fraud Allegations
Amidst growing concerns from lawmakers, the role of major health insurers in the recent termination of 760,000 Affordable Care Act (ACA) policies is under scrutiny following allegations of enrollment fraud.
Senator Tammy Baldwin, alongside several colleagues, has requested clarification from major health insurers like Cigna, UnitedHealthcare, and Elevance Health regarding their involvement in this sweeping action. Their inquiry follows the federal government’s decision, initially announced by Vice President JD Vance on September 22, claiming the removals were due to fraudulent enrollment activities orchestrated by so-called "phantom" enrollees. Senate Democrats have since criticized this rationale, questioning the authenticity of these fraud claims and accusing insurers of complicit behavior in the abrupt cessation of coverage. Dr. Mehmet Oz, who leads the Centers for Medicare and Medicaid Services (CMS), defended the cancellations by noting these enrollees had not utilized healthcare services, which flagged them during the fraud investigation.
Regulatory and Industry Repercussions
The letter highlighted apprehensions about insurers’ adherence to standard procedures for verifying ACA enrollees' eligibility. Senators accused some insurers of submitting potentially misleading data to CMS, possibly in breach of regulatory standards. Insurers reportedly sent requests for Social Security verification, with non-response resulting in classification as "phantom enrollees," leading to their coverage termination as of August 31, 2026. This move sparked criticism for not following due process and failing to adequately notify affected individuals.
The insurers, while contacted for comments, have not yet responded substantively. The continuing silence leaves industry professionals speculating about broader implications, particularly regarding regulatory compliance and consumer communication practices. Insurers could face heightened oversight and possible procedural revisions if found to have played a significant role in the terminations without sufficient evidence of fraud.
Impact on ACA Enrollment
The broader ACA landscape reflects challenges beyond these terminations. According to the U.S. Department of Health and Human Services, ACA enrollments have declined from 21.8 million in February 2025 to 19.2 million in February 2026. One notable factor is the expiration of enhanced subsidies, leading to increased costs for numerous enrollees. This economic pressure may compound enrollment challenges, possibly influencing insurers' market strategies and policy offerings to stabilize membership numbers.
Key Considerations for Insurers
- Procedural Compliance: Insurers must ensure adherence to eligibility verification procedures to prevent regulatory issues.
- Communication Strategies: Clear communication with enrollees about any potential coverage changes is critical to maintain trust.
- Market Adaptation: Rising costs and subsidy changes necessitate strategic adjustments to retain ACA enrollments.
As investigations continue, insurance professionals should monitor these developments closely. The outcome may affect not just the regulatory environment but also broader industry practices surrounding ACA enrollments. For carriers, maintaining compliance while adapting to changing market dynamics will be crucial in navigating these challenges.